sumatriptan has been researched along with cp 135807 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blank, DH; Fox, CB; Koe, BK; Lebel, LA; Macor, JE; Newman, ME; Post, RJ; Ryan, K; Schmidt, AW; Schulz, DW | 1 |
| Ahlgren, C; Eriksson, A; Malmberg, A; Ross, SB; Stenfors, C; Tellefors, P | 1 |
2 other study(ies) available for sumatriptan and cp 135807
| Article | Year |
|---|---|
5-[(3-nitropyrid-2-yl)amino]indoles: novel serotonin agonists with selectivity for the 5-HT1D receptor. Variation of the C3 substituent on the indole template leads to increased 5-HT1D receptor selectivity.
Topics: Indoles; Molecular Conformation; Molecular Structure; Receptors, Serotonin; Serotonin Receptor Agonists; Stereoisomerism; Structure-Activity Relationship; Sumatriptan | 1994 |
In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine(1B) autoreceptor antagonist.
Topics: Animals; Autoreceptors; Benzamides; Binding, Competitive; Cell Line; Cell Membrane; Cerebral Cortex; Dose-Response Relationship, Drug; Electric Stimulation; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Humans; In Vitro Techniques; Indoles; Morpholines; Piperidones; Pyridines; Rabbits; Radioligand Assay; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Saphenous Vein; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Spiro Compounds; Sulfur Radioisotopes; Sumatriptan; Transfection; Tritium; Vasoconstriction; Vasoconstrictor Agents | 2004 |